GLP-1s must now include warning for potential increased risk of vision loss, FDA announces

cbsn fusion glp 1 include warning potential increased risk vision loss fda announces thumbnail



The FDA announced that GLP-1 weight loss drugs will now include warning labels indicating a potential increased risk of vision loss.



Source link

Leave a Reply

Your email address will not be published. Required fields are marked *